Utility of Breath-holding Test in Systemic Sclerosis

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 12, 2020

Primary Completion Date

January 29, 2021

Study Completion Date

May 31, 2023

Conditions
Systemic Sclerosis
Interventions
OTHER

scleroderma health assessment questionnaire (SHAQ), BHT, and 6MWT

"1. Participants will perform the SHAQ.~2. BHT and 6MWT will be performed in the randomized way for each participant.~3. For BHT, the participants will be told to sit comfortably on a chair, and breath normally. After 1 minute, they were required to make a maximum expiration followed by a maximum inspiration and to hold the breath as long as possible at maximum inspiratory level. This procedure was repeated three times, with 5-minute intervals between the tests.~4. 6MWT will be performed according to the ATS guidelines.~5. Information on CXR, TTE, and PFT (FVC%, DLCO%) will be obtained from the medical record if the data was obtained within 3 months. If not, the tests will be performed.~6. BHT and PFT will be followed by six months after the first breath-holding test to confirm the responsiveness.~7. Additional 30 patients with systemic sclerosis will be collected to perform the test-retest reliability of BHT."

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT04484948 - Utility of Breath-holding Test in Systemic Sclerosis | Biotech Hunter | Biotech Hunter